Healthcare technology systems in 2026 and the move to connected care
What healthcare technology systems mean in 2026
Healthcare technology systems now extend well beyond electronic health records. In 2026, the term covers the connected mix of EHRs, medical devices, clinical decision tools, remote monitoring platforms, revenue cycle software, cybersecurity controls, data exchange services and analytics environments that support patient care. The core shift is from digitizing individual tasks to connecting workflows across care teams, devices, payers and patients.
For hospitals, clinics and medical device companies, the practical question is no longer whether a system is digital. It is whether the system can exchange usable data, protect sensitive information, fit clinical work and remain supportable under current regulatory expectations.
This shift matters because the digital foundation is already widespread. ONC reported in 2026 that, as of 2024, 95% of U.S. office-based physicians had adopted any EHR and 91% had adopted a certified EHR. ONC also reported near-universal EHR adoption among non-federal acute care hospitals by 2018, with high levels continuing through 2024. That maturity changes the buying and implementation conversation. The next gains are less about basic adoption and more about integration, governance, reliability and measurable workflow improvement.
For more coverage of digital health, connected devices and hospital IT strategy, visit the healthcare technology section.
The main layers of modern healthcare technology systems
A useful way to evaluate healthcare technology systems is to separate them into layers. Each layer has a different role, but none should be planned in isolation. A monitoring device that cannot feed data into the record creates manual work. A prior authorization platform that does not connect to payer APIs limits automation. An AI tool without auditability can create compliance and trust problems.
| System layer | Typical role | Key evaluation question |
|---|---|---|
| Clinical systems | EHR, computerized provider order entry, e-prescribing, documentation and care coordination | Does the system support the clinician’s actual workflow without avoidable clicks or duplicate entry? |
| Connected medical devices | Patient monitors, imaging equipment, infusion systems, diagnostic devices and remote monitoring tools | Can device data move securely into clinical and operational systems with clear ownership and traceability? |
| Interoperability services | FHIR APIs, health information exchange, patient access and payer-provider data exchange | Does the architecture support standards-based exchange rather than one-off interfaces? |
| Administrative platforms | Scheduling, claims, revenue cycle, prior authorization and supply chain systems | Can administrative workflows connect to clinical events and payer requirements in near real time? |
| Analytics and AI | Dashboards, risk prediction, imaging support, workflow automation and operational forecasting | Are data inputs, performance limits, validation methods and human oversight clearly documented? |
| Security and governance | Identity, access, encryption, monitoring, incident response, vendor risk and audit controls | Can the organization detect, contain and recover from failure without unsafe clinical disruption? |
Why interoperability is now a strategic requirement
Interoperability has moved from an IT goal to a business and clinical requirement. The ONC Cures Act Final Rule pushed the industry toward standardized APIs and patient access to electronic health information. Later Health Data, Technology, and Interoperability rules expanded certification expectations, including algorithm transparency and updated standards. In parallel, ONC’s standards work has continued to expand the United States Core Data for Interoperability, with USCDI v6 released in 2025 and USCDI v7 released on July 23, 2026.
The operational implication is clear: healthcare technology systems that rely heavily on custom data feeds and closed formats are becoming harder to justify. Standards-based exchange does not remove every implementation challenge. It can, however, reduce the long-term cost of connecting EHRs, devices, patient applications, registries, analytics tools and payer systems. It also improves the ability to replace or upgrade one component without rebuilding the entire environment.
CMS policy is adding pressure on payer-provider connectivity. The CMS Interoperability and Prior Authorization Final Rule, published in February 2024, set requirements for APIs that support prior authorization, provider access and payer-to-payer exchange, with many API compliance dates generally beginning January 1, 2027. For provider organizations, this creates a planning window. Technology leaders need to assess whether their EHR, revenue cycle, utilization management and payer connectivity tools can support standards-based prior authorization workflows, rather than simply digitizing fax-era processes.
Medical device systems must be planned as part of the enterprise architecture
Medical devices are no longer peripheral endpoints. Imaging systems, infusion pumps, remote patient monitoring devices, wearables, software as a medical device and AI-enabled diagnostic tools increasingly generate data that affects diagnosis, treatment, documentation, billing and quality reporting. That makes device integration a core design issue for healthcare technology systems.
For medical device manufacturers and provider buyers, three questions should be asked early. First, what data does the device create, and which systems need it? Second, how is cybersecurity managed across the product life cycle? Third, what happens when software updates, model changes or connectivity failures affect clinical operations?
The regulatory environment reinforces this broader view. FDA’s Quality Management System Regulation became effective on February 2, 2026, aligning U.S. medical device quality system requirements more closely with ISO 13485:2016. FDA also issued updated cybersecurity guidance for medical devices in February 2026, emphasizing cybersecurity considerations in device design, labeling and premarket documentation. These developments do not mean every connected device has the same risk profile. They do mean that cybersecurity and quality management can no longer be treated as late-stage documentation exercises.
Cybersecurity and resilience are now care delivery issues
Cybersecurity is often discussed as a technical control problem, but recent healthcare incidents show that it is also a patient access and care continuity problem. The Change Healthcare cyberattack that began in February 2024 disrupted claims, eligibility checks, prior authorization and payment workflows across the U.S. healthcare system. An American Hospital Association survey conducted from March 9 to March 12, 2024, with responses from nearly 1,000 hospitals, found that 74% reported direct patient care impact and 94% reported financial impact.
The lesson for healthcare technology systems is that resilience must be designed into both clinical and administrative workflows. A hospital may have strong endpoint protection and still face major disruption if it cannot process claims, verify coverage, access third-party decision tools or switch to safe downtime procedures. Procurement reviews should therefore examine business continuity, incident response, offline workflows, vendor notification duties and recovery time assumptions.
HHS has also increased attention on healthcare cybersecurity. Its voluntary Healthcare and Public Health Cybersecurity Performance Goals identify high-impact practices intended to reduce common attack vectors. Separately, the HHS Office for Civil Rights issued a HIPAA Security Rule Notice of Proposed Rulemaking in late 2024, with publication in the Federal Register in January 2025, to strengthen cybersecurity protections for electronic protected health information. Because proposals can change before finalization, organizations should not treat every proposed requirement as settled law. They should, however, treat the direction of travel as clear: stronger risk analysis, asset visibility, access control, encryption, audit logging and incident preparedness are becoming baseline expectations. See also: clinical equipment.
AI is becoming a system governance challenge
Artificial intelligence is no longer limited to research pilots. FDA stated that it had authorized more than 1,600 AI-enabled medical devices for marketing in the United States as of September 2026. Many are associated with imaging and diagnostic support, but AI is also appearing in monitoring, triage, documentation, scheduling, coding and operational analytics.
The practical risk is that AI tools can enter healthcare organizations faster than governance programs mature. A device with regulated AI functionality, a clinical decision support feature inside an EHR and an administrative automation tool may each follow different oversight paths. Leaders should avoid grouping them under one vague AI policy. Instead, they should classify systems by intended use, patient impact, regulatory status, data sensitivity and workflow dependency.
Good governance depends on concrete questions. What population was the model evaluated on? Who monitors performance after deployment? Can users understand the output well enough to use it safely? Is there a process for handling drift, bias, false positives, false negatives and software updates? WHO guidance on AI for health and large multimodal models has repeatedly emphasized transparency, human oversight, safety and equity. Those principles are especially important when AI is embedded inside connected healthcare technology systems rather than used as a stand-alone tool.
How to evaluate healthcare technology systems before buying or upgrading
Technology selection should begin with workflow and risk, not feature lists. Many systems look strong in demonstrations because they show the ideal path. Real clinical environments include interruptions, handoffs, incomplete data, emergency exceptions, rotating staff, legacy systems and budget limits. A stronger evaluation process tests the system against those conditions.
- Map the workflow first. Identify who enters data, who consumes it, where decisions occur and where delays currently appear.
- Check standards support. Confirm whether APIs, data formats and terminology standards are implemented in practical ways, not merely listed in marketing material.
- Validate device integration. Determine whether device data enters the EHR or analytics platform automatically, with timestamps, identifiers and audit trails.
- Assess security by design. Review identity management, role-based access, encryption, vulnerability management, logging, patching and incident support.
- Require downtime procedures. Ask how the system functions during outages, cyber incidents, network degradation and third-party service interruptions.
- Review regulatory fit. For medical device software, check FDA status, quality system documentation, cybersecurity documentation and change control processes.
- Measure implementation burden. Estimate training needs, interface work, data migration, governance committees, support staffing and long-term maintenance.
- Define success metrics. Use measurable outcomes such as reduced duplicate documentation, faster authorization turnaround, lower manual device transcription, fewer alert overrides or improved data completeness.
The most successful healthcare technology systems are not necessarily the most complex. They are the ones that fit clinical work, support standards-based exchange, protect data, survive disruption and show evidence that they improve a defined process.
What to watch next
Several near-term developments will shape planning through 2027. Prior authorization API timelines will push payers and providers to connect clinical, administrative and payer data more directly. ONC’s continued expansion of USCDI will increase expectations for richer and more consistent health data exchange. FDA’s QMSR implementation and cybersecurity guidance will keep pressure on medical device manufacturers to integrate quality, software and cyber controls. AI-enabled devices and software tools will also require stronger local governance as adoption grows.
For editors, procurement teams and technology leaders, the issue is not whether healthcare should use more technology. The better question is whether each system strengthens connected care without creating unsafe complexity. In 2026, healthcare technology systems are judged by interoperability, resilience, clinical fit and accountable governance as much as by digital capability.
Frequently asked questions
What are healthcare technology systems?
Healthcare technology systems are the connected digital, device, software, data and security platforms used to deliver, document, manage and improve care. They include EHRs, medical devices, remote monitoring tools, interoperability services, administrative platforms, analytics systems and cybersecurity controls.
Why are healthcare technology systems important for medical device companies?
Medical devices increasingly operate inside connected clinical environments. Device manufacturers need to consider interoperability, cybersecurity, data quality, software updates, regulatory documentation and integration with provider workflows. A clinically useful device may still face adoption barriers if it cannot connect safely and reliably to hospital systems.
What is the biggest risk when upgrading healthcare technology systems?
The biggest risk is treating the upgrade as a software installation rather than a workflow and governance change. Poor data mapping, weak training, unclear ownership, insufficient downtime planning and inadequate cybersecurity review can undermine even technically capable systems.
How should providers prepare for interoperability requirements?
Providers should inventory current interfaces, assess FHIR API readiness, review payer connectivity, confirm EHR certification capabilities, improve data governance and involve clinical, administrative and security teams before compliance deadlines arrive. Preparation should focus on real workflows, not only technical checklists.
